Focus

Devon Park intends to focus primarily on investments in therapeutics – companies that are actively developing compounds that will be advanced through clinical trials prior to being marketed as FDA approved drugs.

Devon Park will also invest in medical device, diagnostic or drug discovery technology companies if they believe that the companies being considered are developing products and/or technologies with the potential to produce a transformation in the way in which a disease is treated or diagnosed or drugs are developed.